Answers are grounded in this paper and cite their sources.
This retrospective study reviewed the charts of children with epilepsy who were followed up in the pediatric neurology clinic of King Fahad Hospital in Al-Baha region, Saudi Arabia, between January 2015 and August 2022. Children between 1 to 14 years of age who had epilepsy, as per the International League against Epilepsy (ILAE) definition, and received anti-seizure medication with a seizure-free period of at least two months before breakthrough seizure episode, were included in the study. Participants under one or more than fourteen years of age, those without a seizure-free period of at least two months before a breakthrough seizure episode, and patients with insufficient information were excluded.
No takes yet. Share an insight, caveat, or question.
Abdullah et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: